Everly Bio

Company Overview

Snapshot

Founded in March 2023 by Michal Gilon Ohev-zion and Noam Shomron, Everly Bio operates with 1–10 employees. The company has raised $1.7 million across one funding round.

Business overview

Everly Bio is a Health Tech & Life Sciences company focused on revolutionizing infertility treatments. The company develops a platform that combines noninvasive technology with novel multisystem molecular insights and advanced computational biology, including Artificial Intelligence, to provide unprecedented decision support in fertility. Everly Bio aims to enable shorter time to pregnancy and increase accessibility to effective solutions for individuals and couples facing infertility, serving both B2C and B2B markets.

Company Intelligence Q&A

When was Everly Bio founded?

Everly Bio was founded in March 2023 by Michal Gilon Ohev-zion and Noam Shomron.

What is Everly Bio's primary focus?

Everly Bio focuses on fertility care, utilizing a molecular platform with advanced computational biology and AI to provide decision support in infertility treatments.

What is the current employee size of Everly Bio?

Everly Bio currently has 1–10 employees.

How much funding has Everly Bio raised to date?

Everly Bio has raised a total of $1.7 million in a Pre-Seed funding round.

What markets does Everly Bio serve?

Everly Bio serves both B2C and B2B markets with its fertility solutions.